Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Vascular Spasm

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2021

Same author

SPOT GRADE II: Clinical Validation of a New Method for Reproducibly Quantifying Surgical Wound Bleeding: Prospective, Multicenter, Multispecialty, Single-Arm Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2020

Same author

Variance estimation for the Kappa statistic in the presence of clustered data and heterogeneous observations.

Statistics in medicine·2020

Same author

Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations.

Journal of cardiac surgery·2019

Same author

Evaluation of the safety and efficacy of a new hemostatic powder using a quantitative surface bleeding severity scale.

Journal of cardiac surgery·2019

Same author

The SPOT GRADE: A New Method for Reproducibly Quantifying Surgical Wound Bleeding.

Spine·2017

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

Active and mechanical hemostatic agents.

William D Spotnitz¹

¹Surgical Therapeutic Advancement Center, University of Virginia Health System, Charlottesville, VA 22908, USA. wspotnitz@bellsouth.net

|November 21, 2007

Summary

Topical sealant and hemostatic agents aid surgical bleeding control, particularly in complex cardiovascular procedures like acute aortic dissection repair. Ongoing research aims to enhance product efficacy, delivery, and safety for wider clinical adoption.

Area of Science:

Biomaterials Science
Surgical Innovation
Cardiovascular Surgery

Background:

Mechanical and active topical agents are available for surgical bleeding control.
These agents serve as adjuncts in various surgical settings.
They are crucial in managing bleeding during complex cardiovascular procedures, such as acute aortic dissection repair.

Purpose of the Study:

To review the current state and future potential of topical sealant and hemostatic agents.
To highlight their importance in cardiovascular surgery.
To discuss ongoing research and development in this field.

Main Methods:

Review of existing literature on topical sealant and hemostatic agents.
Analysis of their application in surgical bleeding control.

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Related Experiment Videos

Last Updated: Jul 10, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Examination of case studies, particularly in acute aortic dissection repair.

Main Results:

Topical sealant and hemostatic agents are effective adjuncts for surgical bleeding control.
Significant utility demonstrated in challenging cardiovascular procedures.
Current products show promise, with ongoing development targeting improvements.

Conclusions:

Mechanical and active topical agents are valuable tools in surgical hemostasis.
Continued research is expected to yield enhanced efficacy, delivery systems, and safety profiles.
These advancements will likely increase the acceptance and application of these agents in clinical practice.